Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
---|
05/06/2003 | US6559312 Intermediates useful for the preparation of antihistaminic piperidine derivatives |
05/06/2003 | US6559311 Process for the synthesis of a photo-stabilizer |
05/06/2003 | US6559307 Process for the preparation of substituted pyrimidines |
05/06/2003 | US6559174 For therapy of AIDS-related dementia, allergic conjunctivitis, allergic rhinitis, Alzheimer's disease, asthma, atherosclerosis, autologous bone marrow transplantation, certain types of toxic and immune-based nephritis |
05/06/2003 | US6559167 Prodrugs of the pyridyl methyl sulfinyl benzimidazole type proton pump inhibitor drugs have a hydrolyzable arylsulfonyl or heteroarylsulfonyl group attached to the benzimidazole nitrogen. The prodrugs of the invention hydrolyze under |
05/06/2003 | US6559166 A class of phenylsulphonyl derivatives wherein the sulphonyl moiety is also attached to an N-arylalkyl-substituted azetidine, pyrrolidine or piperidine ring are selective antagonists of the human 5-HT2A receptor and are therefore |
05/06/2003 | US6559164 Substituted pyrroles suitable for continuous infusion |
05/06/2003 | US6559163 Agonists, antagonists or inverse agonists for GABAA brain receptors; useful in diagnosis and treatment of anxiety, depression |
05/06/2003 | US6559162 Azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias |
05/06/2003 | US6559155 Pyrimidinone derivatives for the treatment of atherosclerosis |
05/06/2003 | US6559153 1-(4-(((4-Amino-6,7-dimethoxy-quinazolin-2-yl)-methyl-amino) methyl)-4-phenyl-piperidin-1-yl)-1-cyclopropyl-methanone; treating disease states ameliorated by blockade of alpha-1 adrenoceptors; sleep/psychological disorders |
05/06/2003 | US6559147 3-((3,5-difluoro-6-(3-(1-methylimidazolin-2-yl)phenoxy)-4 -(2,3 -dihydroxypropoxy)pyridin-2-yl)oxy)-4-hydroxybenzamidine, for example |
05/06/2003 | US6559146 Neuroprotective effects by inducing calbindin D28Kd, one of Ca2+-binding proteins |
05/06/2003 | US6559091 Metal complex ligated by a monodentate, bidentate, tridentate, or tetradentate ligand, wherein at least one of the donor atoms of the ligand is a nitrogen atom substituted by a 1-pyrrolyl or substituted 1- pyrrolyl group |
05/06/2003 | US6558649 Vitronectin receptor antagonist pharmaceuticals |
05/06/2003 | CA2253362C Intracoronary stents containing quinazolinone derivatives |
05/06/2003 | CA2189698C Substituted 1,2,3-triazol-3-ones |
05/02/2003 | EP1306376A1 Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist |
05/02/2003 | EP1306375A1 Salts of benzimidazole compound and use thereof |
05/02/2003 | EP1306374A1 1-(2-chloro-5-methyl-3-pyridylmethyl)-2-nitroiminoimadozolidine and a process for the preparation thereof |
05/02/2003 | EP1306373A1 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient |
05/02/2003 | EP1306085A1 2-Cyclohexyl-4-phenyl-1H-imidazole derivatives as ligands for the neuropeptide Y5 receptor |
05/02/2003 | EP1305319A1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
05/02/2003 | EP1305311A1 Tartrate salt of thiazolidinedione derivative |
05/02/2003 | EP1305308A1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
05/02/2003 | EP1305307A1 Indole derivatives useful for the treatment of cns disorders |
05/02/2003 | EP1305304A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor |
05/02/2003 | EP1305295A1 Imidazole derivatives |
05/02/2003 | EP1305294A2 Imidazolyl derivatives |
05/02/2003 | EP1305291A1 3-substituted isoquinolin-1-yl derivatives |
05/02/2003 | EP1305290A1 Novel heteroaryl derivatives and the use thereof as pharmaceuticals |
05/02/2003 | EP1305270A1 Kinetic resolutions of chiral 2- and 3-substituted carboxylic acids |
05/02/2003 | EP1305048A2 Inhibitors of cellular efflux pumps of microbes |
05/02/2003 | EP1305028A2 Antimicrobial biaryl compounds |
05/02/2003 | EP1196167A4 Method of reducing neuronal injury or apoptosis |
05/02/2003 | EP1086103B1 Pyrido 2,3-b]indolizine derivatives and aza analogues thereof; crf 1 specific ligands |
05/02/2003 | EP1045846B1 Imidazole derivatives having an inhibitory activity for farnesyl transferase and process for preparation thereof |
05/02/2003 | EP1037886B1 Triazine angiogenesis inhibitors |
05/02/2003 | EP0993455B1 POLYMORPHS OF 8-CHLORO-6, 11-DIHYDRO-11- (4-PIPERIDYLIDENE) -5H-BENZO[5,6] CYCLOHEPTA[1,2-b]PYRIDINE |
05/02/2003 | EP0988035B1 Caspases and apoptosis |
05/02/2003 | EP0984957B1 Novel form of s-omeprazole |
05/02/2003 | EP0963371B1 Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase |
05/02/2003 | EP0772593B1 Thiopyridyl compounds for controlling helicobacter bacteria |
05/02/2003 | EP0738150B1 Bicyclic fibrinogen antagonists |
05/02/2003 | EP0724387B1 Angiotension ii receptor antagonists for the treatment of chronic anti-inflammatory diseases |
05/02/2003 | CA2411015A1 5-(alkylidene-cycloalkyl)- and 5-(alkylidene-heterocyclyl)-pyrazoles |
05/02/2003 | CA2411011A1 5-heteroatom-substituted pyrazoles |
05/02/2003 | CA2411009A1 Heterocyclo-alkylsulfonyl pyrazoles |
05/02/2003 | CA2410466A1 Hydrazinyl and nitrogen oxide pyrazoles |
05/02/2003 | CA2410364A1 5-heterocyclo-pyrazoles |
05/01/2003 | WO2003035646A2 Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist |
05/01/2003 | WO2003035645A1 Novel 4-(2-furoyl)aminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same |
05/01/2003 | WO2003035644A1 Benzimidazole derivatives and their use as kdr protein kinase inhibitors |
05/01/2003 | WO2003035643A1 Pyrazolyl-substituted heterocycles and their use as phytosanitary products |
05/01/2003 | WO2003035642A1 Tinuvin p-hindred amine light stabilizer and derivatives thereof, and a process for the preparation thereof |
05/01/2003 | WO2003035641A1 Novel carbamoylpyrrolidone derivative |
05/01/2003 | WO2003035639A1 Pyrimidine compound and medicinal composition thereof |
05/01/2003 | WO2003035638A1 4-imidazolin-2-one compounds |
05/01/2003 | WO2003035627A1 Piperazine derivatives with ccr1 receptor antagonist activity |
05/01/2003 | WO2003035626A2 Azole derivatives and pharmaceutical compositions containing them |
05/01/2003 | WO2003035625A1 Substituted indazole compounds for the treatment of inflammation |
05/01/2003 | WO2003035624A1 Quinoline compound |
05/01/2003 | WO2003035621A1 Protein kinase and phosphatase inhibitors, methods for designing them, and methods of using them |
05/01/2003 | WO2003035620A1 Bicyclic compound |
05/01/2003 | WO2003035618A2 Modulators of phosphoinositide 3-kinase |
05/01/2003 | WO2003035615A2 Tyrosine kinase inhibitors |
05/01/2003 | WO2003035077A1 N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase |
05/01/2003 | WO2003035076A1 Dihydroxypyrimidine carboxamide inhibitors of hiv integrase |
05/01/2003 | WO2003035067A1 Novel dipeptidyl peptidase iv (dp-iv) inhibitors as anti-diabetic agents |
05/01/2003 | WO2003035065A1 Benzimidazoles and analogues and their use as protein kinases inhibitors |
05/01/2003 | WO2003035062A1 Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension |
05/01/2003 | WO2003035057A1 Inhibitors of dipeptidyl peptidase iv |
05/01/2003 | WO2003035009A2 Treatment of acute myeloid leukemia with indolinone compounds |
05/01/2003 | WO2003035005A2 Heteroindanes: a new class of potent cannabimimetic ligands |
05/01/2003 | WO2003005824A3 Substituted 3-heteroaryl (amino-or-oxy)-pyrrolidin-2-ones, method for the production thereof and use thereof as herbicides or as plant growth regulators |
05/01/2003 | WO2003002109A8 Use of tyrosine kinase inhibitors for treating autoimmune diseases |
05/01/2003 | WO2002102782A3 QUINAZOLINE DERIVATIVES which PROMOTE THE RELEASE OF PARATHYROID_HORMONE |
05/01/2003 | WO2002099388A3 Benzodiazepine bradykinin antagonists |
05/01/2003 | WO2002090352A3 Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3 |
05/01/2003 | WO2002079186A3 Aminopiperidine derivatives as modulators of chemokine receptor activity |
05/01/2003 | WO2002076438A3 Flt-1 ligands and their uses in the treatment of diseases regulatable by angiogenesis |
05/01/2003 | WO2002046158A9 Piperidine/piperazine-type inhibitors of p38 kinase |
05/01/2003 | WO2002038553A3 Triazole derivatives and their use as peroxisome proliferator activated receptor alpha agonists |
05/01/2003 | US20030083517 Methods of preparing sulfinamides and sulfoxides |
05/01/2003 | US20030083503 Synthesis of acylated keto amides from sulfonyl amides |
05/01/2003 | US20030083500 Imidazonaphthyridines |
05/01/2003 | US20030083363 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
05/01/2003 | US20030083361 Naphtho(1,2-d)imidazole derivatives; treating thrombocytopenia |
05/01/2003 | US20030083352 Cyclization of a 2-cyano-2-ester-ethylenamine with a primary amine to a 4-ester imidazole |
05/01/2003 | US20030083351 Antihypoxic agents |
05/01/2003 | US20030083350 Pesticides for crop protection |
05/01/2003 | US20030083348 Farnesyl transferase inhibitors |
05/01/2003 | US20030083345 Method of treatment and/or prevention of brain, spinal or nerve injury |
05/01/2003 | US20030083335 CCR1 receptor antagonists; inhibitors of MIP-1 alpha (CCL3) binding to its receptor CCR1 found on inflammatory and immunomodulatory cells; macrophage inflammatory protein (MIP) |
05/01/2003 | US20030083333 1,4-Disubstituted benzo-fused compounds |
05/01/2003 | US20030083332 N-heterocyclic derivatives as NOS inhibitors |
05/01/2003 | US20030083327 Inhibitors of Aurora-2 protein kinases and Glycogen synthase kinase-3 (GSK-3); cancer, diabetes, Alzheimer's disease, and schizophrenia treatment |
05/01/2003 | US20030083325 Serotonin antagonists |
05/01/2003 | US20030083317 HIV inhibiting pyrimidine derivatives |
05/01/2003 | US20030083269 Nictoinamide adenine dinucleotide (NAD); microbiocides; antiseptics; plant safening agents; antibiotic resistance; agriculture; food treatment |